These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34983406)

  • 1. Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database.
    Gupte V; Hegde R; Sawant S; Kalathingal K; Jadhav S; Malabade R; Gogtay J
    BMC Infect Dis; 2022 Jan; 22(1):1. PubMed ID: 34983406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients.
    Platzer M; Totschnig D; Karolyi M; Clodi-Seitz T; Wenisch C; Zoufaly A
    Wien Klin Wochenschr; 2024 Aug; 136(15-16):458-464. PubMed ID: 38884783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience in the use of remdesivir in patients with SARS-CoV-2 pneumonia.
    Murgadella-Sancho A; Gracia-García B; Loureiro-Amigo J; Coloma-Conde A; Losa-López L; Puebla-Villaescusa A
    Farm Hosp; 2021 Aug; 45(5):253-257. PubMed ID: 34806585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Effectiveness of Remdesivir in Adults Hospitalized With Coronavirus Disease 2019 (COVID-19): A Retrospective, Multicenter Comparative Effectiveness Study.
    Garibaldi BT; Wang K; Robinson ML; Betz J; Caleb Alexander G; Andersen KM; Joseph CS; Mehta HB; Korwek K; Sands KE; Fisher AM; Bollinger RC; Xu Y
    Clin Infect Dis; 2022 Aug; 75(1):e516-e524. PubMed ID: 34910128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compassionate Use of Remdesivir in Children With Severe COVID-19.
    Goldman DL; Aldrich ML; Hagmann SHF; Bamford A; Camacho-Gonzalez A; Lapadula G; Lee P; Bonfanti P; Carter CC; Zhao Y; Telep L; Pikora C; Naik S; Marshall N; Katsarolis I; Das M; DeZure A; Desai P; Cao H; Chokkalingam AP; Osinusi A; Brainard DM; Méndez-Echevarría A
    Pediatrics; 2021 May; 147(5):. PubMed ID: 33883243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care.
    Olender SA; Perez KK; Go AS; Balani B; Price-Haywood EG; Shah NS; Wang S; Walunas TL; Swaminathan S; Slim J; Chin B; De Wit S; Ali SM; Soriano Viladomiu A; Robinson P; Gottlieb RL; Tsang TYO; Lee IH; Hu H; Haubrich RH; Chokkalingam AP; Lin L; Zhong L; Bekele BN; Mera-Giler R; Phulpin C; Edgar H; Gallant J; Diaz-Cuervo H; Smith LE; Osinusi AO; Brainard DM; Bernardino JI;
    Clin Infect Dis; 2021 Dec; 73(11):e4166-e4174. PubMed ID: 32706859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis.
    Angamo MT; Mohammed MA; Peterson GM
    Infection; 2022 Feb; 50(1):27-41. PubMed ID: 34331674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
    Gottlieb RL; Vaca CE; Paredes R; Mera J; Webb BJ; Perez G; Oguchi G; Ryan P; Nielsen BU; Brown M; Hidalgo A; Sachdeva Y; Mittal S; Osiyemi O; Skarbinski J; Juneja K; Hyland RH; Osinusi A; Chen S; Camus G; Abdelghany M; Davies S; Behenna-Renton N; Duff F; Marty FM; Katz MJ; Ginde AA; Brown SM; Schiffer JT; Hill JA;
    N Engl J Med; 2022 Jan; 386(4):305-315. PubMed ID: 34937145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of remdesivir or betamethasone on upper respiratory tract SARS-CoV-2 RNA kinetics in hospitalised COVID-19 patients: a retrospective observational study.
    Sourander B; Andersson LM; Brink M; Yilmaz A; Sundell N; Marklund E; Nilsson S; Lindh M; Robertson J; Gisslén M
    Infect Dis (Lond); 2022 Oct; 54(10):703-712. PubMed ID: 35708280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone.
    Leding C; Bodilsen J; Brieghel C; Harboe ZB; Helleberg M; Holm C; Israelsen SB; Jensen J; Jensen TØ; Johansen IS; Johnsen S; Kirk O; Lindegaard B; Meyer CN; Mohey R; Pedersen L; Nielsen H; Nielsen SL; Omland LH; Podlekareva D; Ravn P; Starling J; Storgaard M; Søborg C; Søgaard OS; Tranborg T; Wiese L; Worm SHW; Christensen HR; Benfield T
    Infect Dis (Lond); 2023 May; 55(5):351-360. PubMed ID: 36905638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of remdesivir in patients with COVID-19: a systematic review and meta-analysis.
    Tanni SE; Silvinato A; Floriano I; Bacha HA; Barbosa AN; Bernardo WM
    J Bras Pneumol; 2022; 48(1):e20210393. PubMed ID: 35137874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study.
    Joo EJ; Ko JH; Kim SE; Kang SJ; Baek JH; Heo EY; Shi HJ; Eom JS; Choe PG; Bae S; Ra SH; Kim DY; Kim BN; Kang YM; Kim JY; Chung JW; Chang HH; Bae S; Cheon S; Park Y; Choi H; Lee E; Lee BY; Park JW; Sohn Y; Heo JY; Kim SH; Peck KR
    J Korean Med Sci; 2021 Mar; 36(11):e83. PubMed ID: 33754512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world treatment patterns and clinical outcomes for inpatients with COVID-19 in the US from September 2020 to February 2021.
    Ayodele O; Ren K; Zhao J; Signorovitch J; Jonsson Funk M; Zhu J; Bao Y; Gondek K; Keenan H;
    PLoS One; 2021; 16(12):e0261707. PubMed ID: 34962924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world outcomes of COVID-19 treatment with remdesivir in a Spanish hospital.
    Hidalgo-Tenorio C; García-Vallecillos C; Sequera-Arquelladas S;
    Medicine (Baltimore); 2021 Sep; 100(37):e27228. PubMed ID: 34664862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies assessing the efficacy, effectiveness and safety of remdesivir in management of COVID-19: A scoping review.
    Pimentel J; Laurie C; Cockcroft A; Andersson N
    Br J Clin Pharmacol; 2021 Jul; 87(7):2663-2684. PubMed ID: 33245577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compassionate use of remdesivir in children with COVID-19.
    Méndez-Echevarría A; Pérez-Martínez A; Gonzalez Del Valle L; Ara MF; Melendo S; Ruiz de Valbuena M; Vazquez-Martinez JL; Morales-Martínez A; Remesal A; Sándor-Bajusz KA; Cabañas F; Calvo C
    Eur J Pediatr; 2021 Apr; 180(4):1317-1322. PubMed ID: 33200304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A shorter symptom onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: A real-world analysis.
    Mehta RM; Bansal S; Bysani S; Kalpakam H
    Int J Infect Dis; 2021 May; 106():71-77. PubMed ID: 33647517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness.
    Mechineni A; Kassab H; Manickam R
    Expert Opin Drug Saf; 2021 Nov; 20(11):1299-1307. PubMed ID: 34338121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.